GlassScriptPhysician profile
Heather Danielle Long
NPI 1447983051
$1,087.44
in general payments reported to CMS, 2019-2025
9 companies · $775 in 2025
The $775 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $112 · 2024: $201 · 2025: $775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $983 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $982.74 |
| Education | $104.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $306.80 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $274.99 | 2023-2025 | Dupixent |
| Alnylam Pharmaceuticals INC. | $146.23 | 2025 | Amvuttra |
| Axsome Therapeutics, INC. | $124.38 | 2025 | Auvelity |
| Lundbeck LLC | $96.94 | 2025 | Rexulti |
| Glaxosmithkline, LLC. | $74.64 | 2023-2025 | Nucala, Trelegy Ellipta |
| Itamar Medical INC | $34.25 | 2023-2024 | Watchpatone |
| Merck Sharp & Dohme LLC | $14.76 | 2023 | |
| Hikma Pharmaceuticals USA | $14.45 | 2024 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.